Inhibition of mTOR with rapamycin and an analog, CCI-779, decreased neuroblastoma cell proliferation, indicating a role for the PI3K/AKT/mTOR pathway in tumorigenesis [68]. The gene discussed is AKT1; the disease is neuroblastoma.